Evolent HealthEVH +4.44%66 Receivables Turnover is 1.59 as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 66/100 and a GF Value™ of $11.27 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Evolent Health ranks worse than 70.02% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Evolent Health's Revenue for the
three
months ended in Mar. 2026 was $496 Mil. Evolent Health's average Accounts Receivable for the
three
months ended in Mar. 2026 was $312 Mil.
Hence, Evolent Health's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.59.
Evolent Health (NYSE:EVH) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Evolent Health Receivables Turnover Related Terms
Evolent Health Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Evolent Health's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVH vs PHR, CTEV, MDRX: Receivables Turnover Comparison
For the Health Information Services subindustry, Evolent Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Evolent Health's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (EVH) has a Receivables Turnover of 1.59 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Evolent Health and its competitors. According to the industry distribution chart, Evolent Health ranks #460 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 70%.
Is Evolent Health's Receivables Turnover too high?
Evolent Health's current Receivables Turnover is 1.59. The Healthcare Providers & Services industry median Receivables Turnover is 7.74. Evolent Health's value of 1.59 is 79.5% below this industry median. Based on the distribution chart, Evolent Health ranks #460 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Evolent Health has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Receivables Turnover compare to PHR and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #460 out of 657 companies for Receivables Turnover. This places Evolent Health in the lower half of its industry. The industry median Receivables Turnover is 7.74. Evolent Health's value of 1.59 is 79.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.74, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current Receivables Turnover of 1.59 is 79.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Receivables Turnover is 1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.27, compared to a current price of $5.88 — trading 47.8% below its estimated fair value. The current Receivables Turnover is 1.59 and 79.5% below the Healthcare Providers & Services industry median of 7.74. Evolent Health's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Evolent Health (EVH), the current Receivables Turnover is 1.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.88 is trading 47.8% below its estimated GF Value™ of $11.27.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
Receivables Turnover: 1.59
GF Value™: $11.27 vs. price of $5.88 (47.8% below fair value)
Industry Position: 79.5% below the Healthcare Providers & Services median (#460 of 657)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
66GF Score
Get the complete analysis for EVH
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
